NOAC as possible treatment option in patients with AF after successful TAVI

5' education - Sep. 13, 2021 - Prof. Nicolas van Mieghem, MD, PhD - Erasmus MC, Rotterdam

Educational information

This video was recorded during the digital ESC Congress 2021.

Faculty

Nicolas van Mieghem is professor and clinical director of Interventional Cardiology Thoraxcenter, Erasmus UMC, in Rotterdam, The Netherlands.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read our summary of the ENVISAGE-TAVI AF trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.